plasminogen Chicago III
abnormal variant; from patient with recurring deep vein thrombosis; has both K(m) of activation defect with impaired activator binding & k(cat) of activation defect & impaired Arg(560)-Val peptide bond cleavage
Networked:
0
relevant articles (
0 outcomes,
0 trials/studies)
for this Bio-Agent,
Comments
Bio-Agent Context: Research Results